Junshi Bioscience Lock-Up Expiry: Valuation Still Rich with Few R&D Updates

442 Views24 Jun 2019 17:04

Shanghai Junshi Bioscience Co. Ltd. (1877 HK) was listed on December 2018 and recorded a stellar debut performance thanks to the NDA approval for...

SUMMARY

(Sign Up to Access)

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 4-minute read)

Discussions

(Paid Plans Only)

Top 5%

Asia Pac IPO & Placement Research, China biotech

Aequitas Research

EquitiesEquity Capital MarketsQuantitative Analysis

Price Chart(Sign Up to Access)

Insight Stream